Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

A nasal ‘molecular shield’ developed by researchers may soon block mugwort pollen, offering relief from one of the most ...

Researchers at the Kazakh National Agrarian Research University have developed a pioneering nasal treatment for hay fever ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

The team investigated an IgE antibody called MOv18, exploring its ability to activate immune cells in patients with ovarian cancer and its influence on the tumor's environment.

Recalled by RV Pharma on June 13 due to undeclared peanut allergen. Sold at Aldi locations in 37 states. Customers with ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

According to researchers from the Northwestern University Feinberg School of Medicine, adult-onset food allergies are on the ...

Using the alpha-gal ImmunoCAP assay they already had on hand, Commins started testing blood from their patients with the red meat allergy. 4 Lo and behold, the patients had IgE antibodies to alpha-gal ...